DK563082A - Fremgangsmaade og vektororganisme til styret akkumulation af klonerede heterologe genprodukter i bacillus subtilis ii - Google Patents

Fremgangsmaade og vektororganisme til styret akkumulation af klonerede heterologe genprodukter i bacillus subtilis ii Download PDF

Info

Publication number
DK563082A
DK563082A DK563082A DK563082A DK563082A DK 563082 A DK563082 A DK 563082A DK 563082 A DK563082 A DK 563082A DK 563082 A DK563082 A DK 563082A DK 563082 A DK563082 A DK 563082A
Authority
DK
Denmark
Prior art keywords
heterologous gene
subtilis
reproducts
clonated
heterological
Prior art date
Application number
DK563082A
Other languages
Danish (da)
English (en)
Inventor
Shing Chang
Original Assignee
Cetus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cetus Corp filed Critical Cetus Corp
Publication of DK563082A publication Critical patent/DK563082A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/75—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK563082A 1981-04-20 1982-12-20 Fremgangsmaade og vektororganisme til styret akkumulation af klonerede heterologe genprodukter i bacillus subtilis ii DK563082A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25580481A 1981-04-20 1981-04-20
PCT/US1982/000490 WO1982003633A1 (fr) 1981-04-20 1982-04-20 Procede et organisme vecteur pour l'accumulation commandee de produits de genes heterologues clones dans des bacillus subtilis

Publications (1)

Publication Number Publication Date
DK563082A true DK563082A (da) 1982-12-20

Family

ID=22969947

Family Applications (1)

Application Number Title Priority Date Filing Date
DK563082A DK563082A (da) 1981-04-20 1982-12-20 Fremgangsmaade og vektororganisme til styret akkumulation af klonerede heterologe genprodukter i bacillus subtilis ii

Country Status (12)

Country Link
EP (1) EP0063494B1 (fr)
JP (1) JPS58500590A (fr)
AT (1) ATE48639T1 (fr)
AU (1) AU551529B2 (fr)
CA (1) CA1204681A (fr)
DE (1) DE3280060D1 (fr)
DK (1) DK563082A (fr)
ES (2) ES8308586A1 (fr)
FI (1) FI824238A0 (fr)
IL (1) IL65558A0 (fr)
NO (1) NO824102L (fr)
WO (1) WO1982003633A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8300282A (en) * 1981-04-29 1982-11-04 Biogen N.V. Bacillus cloning vectors and method of expressing foreign dna
US4559300A (en) * 1983-01-18 1985-12-17 Eli Lilly And Company Method for using an homologous bacillus promoter and associated natural or modified ribosome binding site-containing DNA sequence in streptomyces
GR81701B (fr) * 1983-01-18 1984-12-12 Lilly Co Eli
US4595660A (en) * 1983-03-02 1986-06-17 University Of Delaware Molecular cloning with bifunctional plasmid vectors in Bacillus subtilis, mutants and substantially stably transformed mutants of Bacillus subtilis, and methods for utilizing the transformed mutants
US4585739A (en) * 1983-03-07 1986-04-29 E. I. Du Pont De Nemours And Company Plasmid for foreign gene expression in B. subtilis
US4663280A (en) * 1983-05-19 1987-05-05 Public Health Research Institute Of The City Of New York Expression and secretion vectors and method of constructing vectors
US5310675A (en) * 1983-06-24 1994-05-10 Genencor, Inc. Procaryotic carbonyl hydrolases
JPS60137291A (ja) * 1983-12-26 1985-07-20 Takeda Chem Ind Ltd 発現ベクター
US4769327A (en) * 1985-03-29 1988-09-06 Biotechnica International, Inc. Secretion vector
IT1186750B (it) * 1985-07-10 1987-12-16 Eniricerche Spa Vettore di clonaggio,molecole di dna ricombinante,ceppi di bacillus subtilis trasformati con dette molecole e metodi per l'espressione di geni eterologhi e produzione e secrezione di proteine codificate da detti geni

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0005476B1 (fr) * 1978-05-17 1981-12-30 Dr. Karl Thomae GmbH Procédé de préparation d'interféron humain
JPS5564799A (en) * 1978-11-07 1980-05-15 Toray Ind Inc Multi-stage concentration and purification of interferon originated from human fibroblast
NL8000127A (nl) * 1979-01-15 1980-07-17 Harvard College Werkwijze voor het vormen van prokaryotische of eukaryotische proteinen alsmede een daarbij toepasbaar gekoppeld gen.
US4311639A (en) * 1980-07-25 1982-01-19 E. I. Du Pont De Nemours And Company Immunogenic interferon peptides

Also Published As

Publication number Publication date
NO824102L (no) 1982-12-07
WO1982003633A1 (fr) 1982-10-28
EP0063494A2 (fr) 1982-10-27
CA1204681A (fr) 1986-05-20
IL65558A0 (en) 1982-07-30
ES511510A0 (es) 1983-09-16
ES8403158A1 (es) 1984-03-01
AU8521382A (en) 1982-11-04
AU551529B2 (en) 1986-05-01
ES519234A0 (es) 1984-03-01
EP0063494B1 (fr) 1989-12-13
FI824238L (fi) 1982-12-09
EP0063494A3 (en) 1984-02-22
ES8308586A1 (es) 1983-09-16
JPS58500590A (ja) 1983-04-21
DE3280060D1 (de) 1990-01-18
ATE48639T1 (de) 1989-12-15
FI824238A0 (fi) 1982-12-09

Similar Documents

Publication Publication Date Title
ES8306796A1 (es) "un metodo de crear un microorganismo capaz de producir una proteina predeterminada por expresion".
Doi et al. Potential use of Bacillus subtilis for secretion and production of foreign proteins
ES8305045A1 (es) "un procedimiento para obtener una proteina cristalina de b. thuringiensis".
DK563082A (da) Fremgangsmaade og vektororganisme til styret akkumulation af klonerede heterologe genprodukter i bacillus subtilis ii
FI871919A (fi) Sekretionssignalselektionsvektorer foer extracellulaer proteinsyntes hos bacillus-bakterier.
DE3584053D1 (de) Gentechnologisches verfahren zur herstellung von hirudinen und mittel zur durchfuehrung dieses verfahrens.
DK0686195T3 (da) Fremgangsmåde og system til forhöjet produktion af kommercielt vigtige exoproteiner i grampositive bakterier
DK0492964T3 (da) Kloning og ekspression af Borrelialipoproteiner
WO1989007144A3 (fr) Systeme de production d'une proteine avec un rendement eleve
DK0677110T4 (da) Rekombinant mælkesyrebakterie, der indeholder en inserteret promotor
DE3666838D1 (en) Plasmid vectors for expression in escherichia coli and/or bacillus subtilis
EP0164992A3 (fr) Gènes régulateurs pour la fixation de l'azote
HUT40697A (en) Expression vectors containing p down l promotor, presumed restriction places for the substitution of ribosomal bonding places, plasmides containing the vectors, host organisms containing the plasmides and methods relating thereto
IL113307A0 (en) Saf promoter and expression method for expressing foreign dna sequences in streptomyces
Vasantha et al. Fusion of pro region of subtilisin to staphylococcal protein A and its secretion by Bacillus subtilis
EP0467676A2 (fr) Vecteurs d'expression et de sécrétion inductibles par la température et leur utilisation dans des cellules procaryotiques
ATE78870T1 (de) Verfahren zur herstellung von neutraler protease.
DK0410228T3 (da) Termoinducerbar udtrykkelse af heterologe gener i Bacillus subtilis og midler og fremgangsmåder til opnåelse heraf
Greenfield Diphtheria Toxin Expression in Escherichia coli
Balganesh et al. Vector to produce biologically important peptides
ES8506800A1 (es) Un metodo de fabricar un vector de plasmido recombinante deseado.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment